If you are not happy with the results below please do another search
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. The company is based in the UK with offices at the Sussex Innovation Centre.
- Enterprise Therapeutics appoints Dr David Morris MD as Chief Medical OfficerFebruary 10, 2020 - 9:00 am
- Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patientsJanuary 8, 2020 - 10:16 am
- TMEM16A Channel Function Does Not Influence Goblet Cell Numbers or Mucin Secretion In The Human Airway Epithelium – NACFC – Nashville – October 2019November 7, 2019 - 5:32 pm
- EACT Increases Intracellular Calcium Levels by a Tmem16a-Independent Mechanism – NACFC – Nashville – October 2019November 7, 2019 - 5:30 pm
Follow Us On Twitter
Although rapidly becoming the standard of care in #CF, #CFTR modulators do not treat all patients. This review by Enterprise's Henry Danahay & Martin Gosling discusses the current progress with CFTR-independent approaches. Read it @MDPIOpenAccess: https://bit.ly/3aG8UMj #TMEM16A